Argent Biopharma Ltd (RGT.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in thousands)
| 06-2025 | 06-2024 | 06-2023 | 06-2022 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Operating Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 209 | -140 | -739 | -4,018 | -876 |
| Net Acquisitions | N/A | N/A | N/A | -5 | -373 |
| Purchase Of Investment | N/A | N/A | N/A | -156 | N/A |
| Sale Of Investment | N/A | N/A | N/A | N/A | 303 |
| Purchase Sale Intangibles | N/A | N/A | N/A | 151 | N/A |
| Other Investing Activity | 0 | 0 | 790 | 1,735 | 0 |
| Investing Cash Flow | $209 | $-140 | $52 | $-2,443 | $-947 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 7,068 | N/A | 5,750 |
| Debt Repayment | -200 | N/A | 216 | 61 | N/A |
| Common Stock Issued | 10,399 | 15,701 | 2,698 | 10,762 | 12,760 |
| Common Stock Repurchased | N/A | -597 | -81 | -764 | -1,203 |
| Other Financing Activity | -807 | -239 | -590 | -324 | -629 |
| Financing Cash Flow | $9,392 | $14,865 | $9,311 | $9,735 | $16,678 |
| Exchange Rate Effect | 0 | -1 | -488 | -127 | 262 |
| Beginning Cash Position | 703 | 240 | 1,886 | 5,433 | 1,873 |
| End Cash Position | 1,024 | 703 | 240 | 1,768 | 5,433 |
| Net Cash Flow | $322 | $464 | $-1,158 | $-3,538 | $3,297 |
| Free Cash Flow | |||||
| Capital Expenditure | -2 | -140 | -739 | -4,018 | -3,327 |
| Free Cash Flow | -2 | -140 | -739 | -4,018 | -3,327 |